Why is Valiant Laborato falling/rising?

As of 26-Jun, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 113.10, which reflects a decrease of Rs 3.35 or 2.88%. The stock has underperformed its sector by 2.96% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 3.33%. Despite this recent decline, the stock has shown positive performance over the past week and month, with returns of 5.16% and 10.88%, respectively. However, the stock's long-term performance remains concerning, with a significant annual return decline of 18.98% over the past year. Positive factors include a recent increase in institutional investor participation, which rose by 0.64%, and strong quarterly results, such as a higher profit after tax and record net sales. Nevertheless, the company faces challenges with weak long-term fundamentals, including a negative EBITDA and poor growth rates in net sales and operating profit.
In the broader market context, Valiant Laboratories' short-term performance has outpaced the benchmark Sensex, which has returned 2.94% over the past week and 1.92% over the past month. However, the stock's year-to-date performance of 2.12% is significantly lower than the Sensex's 7.19%, indicating a consistent underperformance against the benchmark over the last three years. This underperformance, coupled with the stock's recent price decline, suggests that while there may be some short-term gains, the overall market sentiment remains cautious due to the company's fundamental weaknesses and historical volatility.